SFTPD and interstitial lung disease: Herein, we showed that the prevalence of acute/subacute (A/S)-ILD and the high serum aldolase (ALD) and surfactant protein-D (SP-D) levels and lower %FVC were useful indicators for predicting relapse in anti-ARS-ILD after combination therapy.